Henry Schein, Inc. (NASDAQ:HSIC) Shares Bought by CIBC Asset Management Inc

CIBC Asset Management Inc grew its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 1.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 17,849 shares of the company’s stock after purchasing an additional 169 shares during the period. CIBC Asset Management Inc’s holdings in Henry Schein were worth $1,235,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of HSIC. Cromwell Holdings LLC raised its holdings in shares of Henry Schein by 93.4% during the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after purchasing an additional 170 shares during the period. Versant Capital Management Inc raised its holdings in shares of Henry Schein by 274.6% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $32,000 after purchasing an additional 335 shares during the period. Quent Capital LLC raised its holdings in shares of Henry Schein by 91.2% during the fourth quarter. Quent Capital LLC now owns 677 shares of the company’s stock worth $47,000 after purchasing an additional 323 shares during the period. City State Bank acquired a new stake in shares of Henry Schein during the fourth quarter worth $55,000. Finally, Farther Finance Advisors LLC raised its holdings in shares of Henry Schein by 58.9% during the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock worth $68,000 after purchasing an additional 346 shares during the period. 96.62% of the stock is owned by institutional investors and hedge funds.

Henry Schein Stock Performance

Shares of HSIC opened at $77.24 on Friday. The firm has a 50-day moving average price of $74.14 and a 200 day moving average price of $72.26. The firm has a market capitalization of $9.63 billion, a PE ratio of 31.79, a P/E/G ratio of 2.13 and a beta of 0.91. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 52-week low of $63.67 and a 52-week high of $82.63.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on HSIC. Jefferies Financial Group increased their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a report on Thursday, January 23rd. Mizuho began coverage on shares of Henry Schein in a report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price objective on the stock. Wells Fargo & Company began coverage on shares of Henry Schein in a report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price objective on the stock. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Finally, Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and increased their price objective for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Eight analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $80.09.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.